Eph家族受体在机体生理和病理过程中作用机制的研究进展
Research Progress on the Mechanism of Action of Eph Family Receptors in Physiological and Pathological Processes of the Body
摘要: 促红细胞生成素肝细胞激酶(Erythropoietin-producing hepatocellular, Eph)受体家族作为目前已知最大的酪氨酸激酶受体家族,通过受体–配体结合,介导人类从胚胎发育到成人组织稳态诸多生物学功能的调节,参与机体各种免疫反应。研究发现,Eph受体在包括神经系统发育、细胞迁移、血管形成等许多生理发育过程中起重要作用,在调节免疫反应、肿瘤、炎症、损伤修复等病理过程中也发挥着重要功能。进一步深入的研究Eph家族受体的生物学功能能够更好的对临床疾病进行预防、诊断和治疗,了解调控Eph表达的转录和转录后机制在生物学上具有深远的意义。本篇综述通过从Eph受体家族参与神经发育调节、血管形成、介导免疫反应等方面探讨其在机体生理和病理中的作用机制,总结其在不同机体反应中的作用规律,对临床疾病的诊断、治疗等进一步提供新思路。
Abstract: The Erythropoietin-producing hepatocellular kinase receptor family, as the largest tyrosine kinase receptor family known to date, mediates the regulation of many biological functions from embryon-ic development to adult tissue homeostasis and participates in a variety of immune responses through receptor-ligand binding. It has been found that Eph receptors play important roles in many physiological developmental processes, including nervous system development, cell migration, and blood vessel formation, as well as in the regulation of immune responses, tumors, inflammation, and damage repair. Further in-depth study of the biological functions of the Eph family of receptors can lead to better prevention, diagnosis and treatment of clinical diseases, and understanding the tran-scriptional and post-transcriptional mechanisms that regulate the expression of Eph has far-reaching significance in biology. In this review, we explore the mechanism of Eph receptors in the physiology and pathology of the body from the aspects of their participation in neurodevelop-mental regulation, angiogenesis, and mediation of immune response, and summarize the rules of their roles in different body responses, which will further provide new ideas for the diagnosis and treatment of clinical diseases.
文章引用:董春旭, 朱国强, 黄立. Eph家族受体在机体生理和病理过程中作用机制的研究进展[J]. 临床医学进展, 2023, 13(12): 19352-19359. https://doi.org/10.12677/ACM.2023.13122724

参考文献

[1] 刘正, 邵子玮, 袁文华, 等. Eph/ephrin信号通路与神经干细胞的增殖和分化[J] 中国组织工程研究, 2019, 23(13): 2101-2106.
[2] Hirai, H., Maru, Y., Hagiwara, K., et al. (1987) A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene. Science, 238, 1717-1720. [Google Scholar] [CrossRef] [PubMed]
[3] Papadakos, S.P., Dedes, N., Gkolemi, N., Machairas, N. and Theocharis, S. (2023) The EPH/Ephrin System in Pancreatic Ductal Adenocarcino-ma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences, 24, Article 3015. [Google Scholar] [CrossRef] [PubMed]
[4] Sahoo, A.R. and Buck, M. (2021) Structural and Functional Insights into the Transmembrane Domain Association of Eph Receptors. International Journal of Molecular Sciences, 22, Article 8593. [Google Scholar] [CrossRef] [PubMed]
[5] Pasquale, E.B. (2005) Eph Receptor Signalling Casts a Wide Net on Cell Behaviour. Nature Reviews Molecular Cell Biology, 6, 462-475. [Google Scholar] [CrossRef] [PubMed]
[6] De Boer, E.C.W., van Gils, J.M. and van Gils, M.J. (2020) Ephrin-Eph Signaling Usage by a Variety of Viruses. Pharma-cological Research, 159, Article ID: 105038. [Google Scholar] [CrossRef] [PubMed]
[7] Xiao, T., Xiao, Y., Wang, W., et al. (2020) Targeting EphA2 in Cancer. Journal of Hematology & Oncology, 13, Article No. 114. [Google Scholar] [CrossRef] [PubMed]
[8] Liang, L.Y., Patel, O., Janes, P.W., Murphy, J.M. and Lucet, I.S. (2019) Eph Receptor Signalling: From Catalytic to Non-Catalytic Functions. Oncogene, 38, 6567-6584. [Google Scholar] [CrossRef] [PubMed]
[9] Shiuan, E. and Chen, J. (2016) Eph Receptor Tyrosine Kinases in Tumor Immunity. Cancer Research, 76, 6452-6457. [Google Scholar] [CrossRef
[10] Darling, T.K. and Lamb, T.J. (2019) Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity. Frontiers in Immunology, 10, Article 1473. [Google Scholar] [CrossRef] [PubMed]
[11] Janes, P.W., Vail, M.E., Ernst, M. and Scott, A.M. (2021) Eph Receptors in the Immunosuppressive Tumor Microenvironment. Cancer Research, 81, 801-805. [Google Scholar] [CrossRef
[12] Alonso, C.L., Trinidad, E.M., de Garcillan, B., et al. (2009) Expression Profile of Eph Receptors and Ephrin Ligands in Healthy Human B Lymphocytes and Chronic Lymphocytic Leukemia B-Cells. Leukemia Research, 33, 395-406. [Google Scholar] [CrossRef] [PubMed]
[13] Jellinghaus, S., Poitz, D.M., Ende, G., et al. (2013) Ephrin-A1/EphA4-Mediated Adhesion of Monocytes to Endothelial Cells. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1833, 2201-2211. [Google Scholar] [CrossRef] [PubMed]
[14] Pfaff, D., Héroult, M., Riedel, M., et al. (2008) Involvement of Endothelial Ephrin-B2 in Adhesion and Transmigration of EphB-Receptor-Expressing Monocytes. Journal of Cell Sci-ence, 121, 3842-3850. [Google Scholar] [CrossRef] [PubMed]
[15] Ivanov, A.I. and Romanovsky, A.A. (2006) Puta-tive Dual Role of Ephrin-Eph Receptor Interactions in Inflammation. IUBMB Life, 58, 389-394. [Google Scholar] [CrossRef] [PubMed]
[16] Muñoz, J.J., Cejalvo, T., Alonso-Colmenar, L.M., et al. (2011) Eph/Ephrin-Mediated Interactions in the Thymus. Neuroimmunomodulation, 18, 271-280. [Google Scholar] [CrossRef] [PubMed]
[17] Alfaro, D., García-Ceca, J.J., Cejalvo, T., et al. (2007) EphrinB1-EphB Signaling Regulates Thymocyte-Epithelium Interactions Involved in Functional T Cell Development. European Journal of Immunology, 37, 2596-2605. [Google Scholar] [CrossRef] [PubMed]
[18] Muñoz, J.J., Alfaro, D., García-Ceca, J., et al. (2006) Thymic Altera-tions in EphA4-Deficient Mice. The Journal of Immunology, 177, 804-813. [Google Scholar] [CrossRef] [PubMed]
[19] Sharfe, N., Nikolic, M., Cimpeon, L., et al. (2008) EphA and Ephrin-A Proteins Regulate Integrin-Mediated T Lymphocyte Interactions. Molecular Immunology, 45, 1208-1220. [Google Scholar] [CrossRef] [PubMed]
[20] Diegelmann, R.F. and Evans, M.C. (2004) Wound Healing: An Overview of Acute, Fibrotic and Delayed Healing. Frontiers in Bioscience, 9, 283-289. [Google Scholar] [CrossRef] [PubMed]
[21] Coulthard, M.G., Morgan, M., Woodruff, T.M., et al. (2012) Eph/Ephrin Sig-naling in Injury and Inflammation. The American Journal of Pathology, 181, 1493-1503. [Google Scholar] [CrossRef] [PubMed]
[22] Fabes, J., Anderson, P., Brennan, C. and Bolsover, S. (2007) Regeneration-Enhancing Effects of EphA4 Blocking Peptide Following Corticospinal Tract Injury in Adult Rat Spinal Cord. European Journal of Neuroscience, 26, 2496-2505. [Google Scholar] [CrossRef] [PubMed]
[23] Carmichael, S.T. (2003) Gene Expression Changes after Focal Stroke, Traumatic Brain and Spinal Cord Injuries. Current Opinion in Neurology, 16, 699-704. [Google Scholar] [CrossRef] [PubMed]
[24] Hong, J.Y., et al. (2015) EphA2 Receptor Signaling Mediates Inflammatory Responses in Lipopolysaccharide-Induced Lung Injury. Tuberculosis and Respiratory Diseases, 78, 218-226. [Google Scholar] [CrossRef] [PubMed]
[25] Kaplan, N., et al. (2012) EphA2/Ephrin-A1 Signaling Complexes Restrict Corneal Epithelial Cell Migration. Investigative Ophthalmology & Visual Science, 53, 936-945. [Google Scholar] [CrossRef] [PubMed]
[26] Wijeratne, D., et al. (2019) Ephrin-A2 Affects Wound Healing and Scar-ring in a Murine Model of Excisional Injury. Burns, 45, 682-690. [Google Scholar] [CrossRef] [PubMed]
[27] Cheng, N., Brantley, D.M. and Chen, J. (2002) The Ephrins and Eph Receptors in Angiogenesis. Cytokine & Growth Factor Reviews, 13, 75-85. [Google Scholar] [CrossRef
[28] Larson, J., Schomberg, S., Schroeder, W., and Carpenter, T.C. (2008) Endothelial EphA Receptor Stimulation Increases Lung Vascular Permeability. American Journal of Physi-ology-Lung Cellular and Molecular Physiology, 295, L431-L439. [Google Scholar] [CrossRef] [PubMed]
[29] Cercone, M.A., Schroeder, W., Schomberg, S., et al. (2009) EphA2 Receptor Mediates Increased Vascular Permeability in Lung Injury due to Viral Infection and Hypoxia. American Journal of Physiology-Lung Cellular and Molecular Physiology, 297, L856-L863. [Google Scholar] [CrossRef] [PubMed]
[30] Kuijper, S., Turner, C.J. and Adams, R.H. (2007) Regulation of Angiogenesis by Eph-Ephrin Interactions. Trends in Cardiovascular Medicine, 17, 145-151. [Google Scholar] [CrossRef] [PubMed]
[31] Stephen, L.J., Fawkes, A.L., Verhoeve, A., Lemke, G. and Brown, A. (2007) A Critical Role for the EphA3 Receptor Tyrosine Kinase in Heart Development. Developmental Biology, 302, 66-79. [Google Scholar] [CrossRef] [PubMed]
[32] Frieden, L.A., et al. (2010) Regulation of Heart Valve Morpho-genesis by Eph Receptor Ligand, Ephrin-A1. Developmental Dynamics, 239, 3226-3234. [Google Scholar] [CrossRef] [PubMed]
[33] Salvucci, O. and Tosato, G. (2012) Essential Roles of EphB Receptors and EphrinB Ligands in Endothelial Cell Function and Angiogenesis. Advances in Cancer Research, 114, 21-57. [Google Scholar] [CrossRef
[34] Barquilla, A. and Pasquale, E.B. (2015) Eph Receptors and Ephrins: Therapeutic Opportunities. Annual Review of Pharmacology and Toxicology, 55, 465-487. [Google Scholar] [CrossRef] [PubMed]
[35] Wu, Z.H., et al. (2012) Possible Role of Efnb1 Protein, a Ligand of Eph Receptor Tyrosine Kinases, in Modulating Blood Pressure. Journal of Biological Chemistry, 287, 15557-15569. [Google Scholar] [CrossRef
[36] Pasquale, E.B. (2010) Eph Receptors and Ephrins in Cancer: Bidirectional Signalling and beyond. Nature Reviews Cancer, 10, 165-180. [Google Scholar] [CrossRef] [PubMed]
[37] Miao, H. and Wang, B.C. (2012) EphA Receptor Signaling—Complexity and Emerging Themes. Seminars in Cell & Developmental Biology, 23, 16-25. [Google Scholar] [CrossRef] [PubMed]
[38] Nishimura, M., et al. (2013) Therapeutic Synergy between mi-croRNA and siRNA in Ovarian Cancer Treatment. Cancer Discovery, 3, 1302-1315. [Google Scholar] [CrossRef
[39] Arvanitis, D.N. and Davy, A. (2012) Regulation and Misreg-ulation of Eph/Ephrin Expression. Cell Adhesion & Migration, 6, 131-137. [Google Scholar] [CrossRef] [PubMed]
[40] Lisabeth, E.M., Fernandez, C. and Pasquale, E.B. (2012) Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase through Multiple Mechanisms. Biochemistry, 51, 1464-1475. [Google Scholar] [CrossRef] [PubMed]
[41] Zhuang, G.L., et al. (2012) Effects of Cancer-Associated EPHA3 Muta-tions on Lung Cancer. Journal of the National Cancer Institute, 104, 1183-1198. [Google Scholar] [CrossRef] [PubMed]
[42] Gökmen-Polar, Y., et al. (2011) Dual Targeting of EphA2 and ER Restores Tamoxifen Sensitivity in ER/EphA2-Positive Breast Cancer. Breast Cancer Research and Treatment, 127, 375-384. [Google Scholar] [CrossRef] [PubMed]
[43] Zhuang, G.L., et al. (2010) Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy. Cancer Research, 70, 299-308. [Google Scholar] [CrossRef
[44] Li, J.L., et al. (2011) DLL4-Notch Signaling Mediates Tu-mor Resistance to Anti-VEGF Therapy in vivo. Cancer Research, 71, 6073-9083. [Google Scholar] [CrossRef
[45] Yamaguchi, Y. and Pasquale, E.B. (2004) Eph Receptors in the Adult Brain. Current Opinion in Neurobiology, 14, 288-296. [Google Scholar] [CrossRef] [PubMed]
[46] Pasquale, E.B. (2008) Eph-Ephrin Bidirectional Signaling in Physiology and Disease. Cell, 133, 38-52. [Google Scholar] [CrossRef] [PubMed]
[47] Hruska, M. and Dalva, M.B. (2012) Ephrin Regulation of Synapse Formation, Function and Plasticity. Molecular and Cellular Neuroscience, 50, 35-44. [Google Scholar] [CrossRef] [PubMed]
[48] Holmberg, J., Clarke, D.L. and Frisén, J. (2000) Regulation of Re-pulsion versus Adhesion by Different Splice Forms of an Eph Receptor. Nature, 408, 203-206. [Google Scholar] [CrossRef] [PubMed]
[49] Ji, Y.J., et al. (2014) EphrinB2 Affects Apical Constriction in Xenopus Embryos and Is Regulated by ADAM10 and Flotillin-1. Nature Communications, 5, Article No. 3516. [Google Scholar] [CrossRef] [PubMed]
[50] Depaepe, V., et al. (2005) Ephrin Signalling Controls Brain Size by Regulating Apoptosis of Neural Progenitors. Nature, 435, 1244-1250. [Google Scholar] [CrossRef] [PubMed]
[51] Arvanitis, D.N., et al. (2013) Ephrin B1 Maintains Apical Adhesion of Neural Progenitors. Development, 140, 2082-2092. [Google Scholar] [CrossRef] [PubMed]
[52] Feng, G., et al. (2000) Roles for Ephrins in Positionally Selective Synap-togenesis between Motor Neurons and Muscle Fibers. Neuron, 25, 295-306. [Google Scholar] [CrossRef
[53] Kayser, M.S., Nolt, M.J. and Dalva, M.B. (2008) EphB Re-ceptors Couple Dendritic Filopodia Motility to Synapse Formation. Neuron, 59, 56-69. [Google Scholar] [CrossRef] [PubMed]
[54] Clifford, M.A., et al. (2014) EphA7 Signaling Guides Cortical Dendritic Development and Spine Maturation. Proceedings of the National Academy of Sciences of the United States of America, 111, 4994-4999. [Google Scholar] [CrossRef] [PubMed]
[55] Du, J., Fu, C. and Sretavan, D.W. (2007) Eph/Ephrin Signaling as a Potential Therapeutic Target after Central Nervous System Injury. Current Pharmaceutical Design, 13, 2507-2518. [Google Scholar] [CrossRef] [PubMed]
[56] Kempf, A., et al. (2013) Upregulation of Axon Guidance Mol-ecules in the Adult Central Nervous System of Nogo—A Knockout Mice Restricts Neuronal Growth and Regeneration. European Journal of Neuroscience, 38, 3567-3579. [Google Scholar] [CrossRef] [PubMed]
[57] Goldshmit, Y., et al. (2011) EphA4 Blockers Promote Axonal Regeneration and Functional Recovery Following Spinal Cord Injury in Mice. PLOS ONE, 6, e24636. [Google Scholar] [CrossRef] [PubMed]
[58] Van Hoecke, A., et al. (2012) EPHA4 Is a Disease Modifier of Amyotrophic Lateral Sclerosis in Animal Models and in Humans. Nature Medicine, 18, 1418-1422. [Google Scholar] [CrossRef] [PubMed]
[59] Lin, S., Wang, B. and Getsios, S. (2012) Eph/Ephrin Signaling in Epidermal Differentiation and Disease. Seminars in Cell & Developmental Biology, 23, 92-101. [Google Scholar] [CrossRef] [PubMed]
[60] Gordon, K., Kochkodan, J.J., Blatt, H., et al. (2013) Alteration of the EphA2/Ephrin—A Signaling Axis in Psoriatic Epidermis. Journal of Investigative Dermatology, 133, 712-722. [Google Scholar] [CrossRef] [PubMed]
[61] Genander, M., Holmberg, J. and Frisén, J. (2010) Ephrins Negatively Regulate Cell Proliferation in the Epidermis and Hair Follicle. Stem Cells, 28, 1196-1205. [Google Scholar] [CrossRef] [PubMed]
[62] Zhao, C., (2006) Bidirectional Ephrinb2-EphB4 Signaling Controls Bone Homeostasis. Cell Metabolism, 4, 111-121. [Google Scholar] [CrossRef] [PubMed]
[63] Cheng, S.H., et al. (2012) Targeted Disruption of Ephrin B1 in Cells of Myeloid Lineage Increases Osteoclast Differentiation and Bone Resorption in Mice. PLOS ONE, 7, e32887. [Google Scholar] [CrossRef] [PubMed]
[64] Szepietowska, B., Zhu, W.L., Czyzyk, J., Eid, T. and Sherwin, R.S. (2013) EphA5-EphrinA5 Interactions within the Ventromedial Hypothalamus Influence Counterregulatory Hormone Release and Local Glutamine/Glutamate Balance during Hypoglycemia. Diabetes, 62, 1282-1288. [Google Scholar] [CrossRef] [PubMed]
[65] Jain, R., et al. (2013) Pharmacological Inhibition of Eph Receptors En-hances Glucose-Stimulated Insulin Secretion from Mouse and Human Pancreatic Islets. Diabetologia, 56, 1350-1355. [Google Scholar] [CrossRef] [PubMed]